Cite item

Vitaherpavac is the first Russian herpes simplex virus vaccine obtained on the Vero B continuous cell line

  
Barkhaleva O.A., Ladyzhenskaya I.P., Vorobyeva M.S., Shalunova N.V., Podchernyaeva R.Y., Mikhailova G.R., Khorosheva T.V., Barinsky I.F. Vitaherpavac is the first Russian herpes simplex virus vaccine obtained on the Vero B continuous cell line // Problems of Virology. - 2009. - Vol. 54. - N. 5. - P. 33-37.